|
Market Closed -
OTC Markets
21:45:29 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | 0.00% |
|
0.00% | - |
| Market Cap | 716K 641K 590K 534K 999K 67.98M 1.02M 7.03M 2.82M 35.76M 2.69M 2.63M 113M | P/E 2024 |
-0.6x | P/E 2025 | -0.38x |
|---|---|---|---|---|---|
| Enterprise Value | 12.04M 10.78M 9.92M 8.99M 16.8M 1.14B 17.11M 118M 47.47M 601M 45.18M 44.22M 1.9B | EV / Sales 2024 |
27.1x | EV / Sales 2025 | 31.2x |
| Free-Float |
98.98% | Yield 2024 * |
-
| Yield 2025 | - |
| 6 months | -66.67% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0 |
| 10 years | 0 | | 0.02 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Flax
CEO | Chief Executive Officer | 56 | 01/11/2001 |
Joe Lucas
COO | Chief Operating Officer | - | - |
| Chief Tech/Sci/R&D Officer | 64 | 27/07/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Garry Pottruck
BRD | Director/Board Member | 68 | 29/07/2009 |
Stewart Lonky
BRD | Director/Board Member | 78 | 05/11/2004 |
Michael Flax
BRD | Director/Board Member | 56 | 01/11/2001 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/21/26 A | Don | Executive/Senior Manager | -12,000,000 | 100.0000% | ||
| 8/21/26 A | Other | Executive/Senior Manager | 0 | 0% | ||
| 11/15/21 A | Buy | Executive/Senior Manager | 12,000,000 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | 0.00% | 0.00% | 716K | |
| +3.19% | +11.31% | +67.86% | +150.58% | 1,263B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 658B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 521B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 391B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 369B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 307B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 290B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 252B | |
| +3.06% | +9.38% | +44.11% | +119.47% | 212B | |
| Average | +1.56% | +5.31% | +41.93% | +74.82% | 426.19B | |
| Weighted average by Cap. | +1.19% | +6.60% | +50.88% | +98.31% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 392K 351K 323K 293K 547K 37.23M 557K 3.85M 1.55M 19.59M 1.47M 1.44M 61.77M | 385K 345K 317K 288K 538K 36.59M 548K 3.79M 1.52M 19.24M 1.45M 1.42M 60.69M |
| Net income | -1.29M -1.15M -1.06M -960K -1.79M -122M -1.83M -12.63M -5.07M -64.21M -4.82M -4.72M -203M | -2.05M -1.83M -1.69M -1.53M -2.86M -194M -2.91M -20.11M -8.07M -102M -7.68M -7.52M -322M |
| Net Debt | 9.91M 8.87M 8.16M 7.4M 13.82M 941M 14.08M 97.34M 39.08M 495M 37.19M 36.39M 1.56B | 11.32M 10.14M 9.33M 8.45M 15.8M 1.08B 16.09M 111M 44.65M 566M 42.49M 41.59M 1.78B |
Employees
6
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | $0.000100 | 0.00% | 721,263 |
| 27/10/26 | $0.000100 | 0.00% | 125 |
| 23/10/26 | $0.000100 | 0.00% | 234,500 |
| 22/10/26 | $0.000100 | 0.00% | 150,000 |
- Stock Market
- Stocks
- NPHC Stock
Select your edition
All financial news and data tailored to specific country editions
